Free tool
Stocks listed on B3 São Paulo
We cover 64 companies listed on B3 São Paulo. The median market value in the group is $32.60B. Across the group, the median move over the past trading day is 0.00%. 49% of the 63 with a 200-day average trade above it. Price change over the past year runs from −76.9% to +44.2% across the middle 80 percent of the group, with a median of +1.1%.
Other lists in this group
Table
64 of 2,037 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| ABTT34.SA | Abbott Laboratories | $199.23B | Large cap | −16.35% |
| GILD34.SA | Gilead Sciences, Inc. | $184.15B | Large cap | −79.11% |
| PFIZ34.SA | Pfizer Inc. | $161.53B | Large cap | +11.58% |
| DHER34.SA | Danaher Corporation | $151.72B | Large cap | +0.89% |
| VRTX34.SA | Vertex Pharmaceuticals Incorporated | $139.70B | Large cap | −83.18% |
| BMYB34.SA | Bristol-Myers Squibb Company | $138.65B | Large cap | +40.74% |
| I1SR34.SA | Intuitive Surgical, Inc. | $132.60B | Large cap | −25.36% |
| S1YK34.SA | Stryker Corporation | $126.60B | Large cap | −19.51% |
| MDTC34.SA | Medtronic plc | $118.37B | Large cap | −75.74% |
| G1SK34.SA | GSK plc | $104.64B | Large cap | +27.31% |
| M1CK34.SA | McKesson Corporation | $104.59B | Large cap | −92.49% |
| H1CA34.SA | HCA Healthcare, Inc. | $92.89B | Large cap | +2.99% |
| E1LV34.SA | Elevance Health, Inc. | $86.53B | Large cap | +21.66% |
| REGN34.SA | Regeneron Pharmaceuticals, Inc. | $85.16B | Large cap | +33.80% |
| C1IC34.SA | The Cigna Group | $73.39B | Large cap | −85.33% |
| B1SX34.SA | Boston Scientific Corporation | $70.04B | Large cap | −89.24% |
| M1RN34.SA | Moderna, Inc. | $63.51B | Large cap | +462.13% |
| A1RG34.SA | argenx SE | $63.16B | Large cap | +36.97% |
| TAKP34.SA | Takeda Pharmaceutical Company Limited | $57.22B | Large cap | +18.03% |
| C1AH34.SA | Cardinal Health, Inc. | $55.77B | Large cap | +52.41% |
| C1CO34.SA | Cencora, Inc. | $52.41B | Large cap | −12.17% |
| B1DX34.SA | Becton, Dickinson and Company | $51.78B | Large cap | −113.87% |
| E1WL34.SA | Edwards Lifesciences Corporation | $47.29B | Large cap | −4.72% |
| H1UM34.SA | Humana Inc. | $46.72B | Large cap | +24.36% |
| I1DX34.SA | IDEXX Laboratories, Inc. | $44.35B | Large cap | −17.31% |
| T1EV34.SA | Teva Pharmaceutical Industries Limited | $44.24B | Large cap | +94.70% |
| V2EE34.SA | Veeva Systems Inc. | $41.01B | Large cap | −18.65% |
| A1GI34.SA | Agilent Technologies, Inc. | $39.64B | Large cap | −77.37% |
| WATC34.SA | Waters Corporation | $36.35B | Large cap | +24.76% |
| I1LM34.SA | Illumina, Inc. | $34.10B | Large cap | +113.13% |
| D1EX34.SA | DexCom, Inc. | $33.75B | Large cap | +9.64% |
| C1NC34.SA | Centene Corporation | $32.65B | Large cap | +116.61% |
| BIIB34.SA | Biogen Inc. | $32.56B | Large cap | +47.86% |
| Z1TS34.SA | Zoetis Inc. | $32.03B | Large cap | −52.31% |
| A1LN34.SA | Alnylam Pharmaceuticals, Inc. | $31.78B | Large cap | −49.35% |
| B1NT34.SA | BioNTech SE | $28.32B | Large cap | +2.68% |
| R1MD34.SA | ResMed Inc. | $27.33B | Large cap | −38.24% |
| I1NC34.SA | Incyte Corporation | $25.83B | Large cap | +41.91% |
| S1TE34.SA | STERIS plc | $19.75B | Large cap | −18.78% |
| Z1BH34.SA | Zimmer Biomet Holdings, Inc. | $18.07B | Large cap | −5.04% |
| N1BI34.SA | Neurocrine Biosciences, Inc. | $15.65B | Large cap | +7.37% |
| C1OO34.SA | The Cooper Companies, Inc. | $15.12B | Large cap | −0.89% |
| RDOR3.SA | Rede D'Or São Luiz S.A. | $14.92B | Large cap | +1.37% |
| B1AX34.SA | Baxter International Inc. | $13.60B | Large cap | +3.61% |
| S1NN34.SA | Smith & Nephew plc | $12.87B | Large cap | −20.44% |
| B1MR34.SA | BioMarin Pharmaceutical Inc. | $12.54B | Large cap | +4.97% |
| R1VT34.SA | Revvity, Inc. | $12.50B | Large cap | +22.81% |
| DVAI34.SA | DaVita Inc. | $11.70B | Large cap | +18.80% |
| T1CH34.SA | Bio-Techne Corporation | $11.51B | Large cap | +23.42% |
| A1LG34.SA | Align Technology, Inc. | $11.51B | Large cap | +7.83% |
| I1QV34.SA | IQVIA Holdings Inc. | $10.82B | Large cap | −67.19% |
| U1HS34.SA | Universal Health Services, Inc. | $10.55B | Large cap | −6.44% |
| R1DY34.SA | Dr. Reddy's Laboratories Limited | $9.95B | Mid cap | −20.54% |
| E2XE34.SA | Exelixis, Inc. | $6.61B | Mid cap | +23.92% |
| RADL3.SA | Raia Drogasil S.A. | $6.56B | Mid cap | +7.42% |
| T1FX34.SA | Teleflex Incorporated | $6.00B | Mid cap | +0.29% |
| A2LC34.SA | Alcon Inc. | $3.57B | Mid cap | −12.15% |
| HYPE3.SA | Hypera S.A. | $2.98B | Mid cap | −4.69% |
| CLOV34.SA | Clover Health Investments, Corp. | $2.15B | Mid cap | +45.23% |
| QUAL3.SA | Qualicorp Consultoria e Corretora de Seguros S.A. | $90.10M | Micro cap | −11.35% |
| AALR3.SA | Alliança Saúde e Participações S.A. | $87.57M | Micro cap | −52.03% |
| DMVF3.SA | d1000 Varejo Farma Participações S.A. | $60.44M | Micro cap | +29.47% |
| VVEO3.SA | CM Hospitalar S/A | $42.35M | Micro cap | −24.72% |
| BALM4.SA | Baumer S.A. | $29.30M | Micro cap | +22.57% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.